1. Home
  2. CTSO vs CELU Comparison

CTSO vs CELU Comparison

Compare CTSO & CELU Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Cytosorbents Corporation

CTSO

Cytosorbents Corporation

SELL

Current Price

$4.52

Market Cap

23.9M

Sector

Health Care

ML Signal

SELL

Logo Celularity Inc.

CELU

Celularity Inc.

HOLD

Current Price

$0.44

Market Cap

26.5M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CTSO
CELU
Founded
1997
2016
Country
United States
United States
Employees
N/A
N/A
Industry
Medical/Dental Instruments
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
23.9M
26.5M
IPO Year
2008
2019

Fundamental Metrics

Financial Performance
Metric
CTSO
CELU
Price
$4.52
$0.44
Analyst Decision
Analyst Count
0
0
Target Price
★ $32.50
N/A
AVG Volume (30 Days)
22.2K
★ 182.4K
Earning Date
11-12-2026
12-01-2026
Dividend Yield
N/A
N/A
EPS Growth
★ 65.79
N/A
EPS
N/A
★ 0.04
Revenue
$22,503,908.00
★ $26,550,000.00
Revenue This Year
$2.14
$165.42
Revenue Next Year
$16.24
$305.36
P/E Ratio
★ N/A
$11.70
Revenue Growth
★ 48.53
N/A
52 Week Low
$0.30
$0.46
52 Week High
$7.44
$2.55

Technical Indicators

Market Signals
Indicator
CTSO
CELU
Relative Strength Index (RSI) 46.03 25.58
Support Level $2.88 N/A
Resistance Level $7.20 $0.83
Average True Range (ATR) 0.79 0.10
MACD -0.07 -0.01
Stochastic Oscillator 15.43 6.38

Price Performance

Historical Comparison
CTSO
CELU

About CTSO Cytosorbents Corporation

CytoSorbents Corp is a leader in blood purification for the treatment of life-threatening conditions in the intensive care unit and cardiac surgery. CytoSorbent's proprietary blood purification technologies are based on biocompatible, high-porous polymer beads that can actively remove toxic substances from blood and other bodily fluids by pore capture and surface adsorption. CytoSorbent's technologies are used in several broad applications. Specifically, two important applications are: the removal of blood thinners during and after cardiothoracic surgery to reduce the risk of severe bleeding, and the removal of inflammatory agents and toxins in common critical illnesses that can cause massive inflammation, organ failure, and patient death. Geographically, in the USA, Germany, and Others.

About CELU Celularity Inc.

Celularity Inc is a regenerative and cellular medicine company focused on developing placental-derived allogeneic cell therapies and biomaterial products for the treatment of degenerative diseases, aging-related conditions, cancer, and immune disorders. The company operates through three segments: Cell Therapy, Degenerative Disease, and BioBanking. It generates the majority of its revenue from the Degenerative Disease segment.

Share on Social Networks: